VRTX RSI Chart
Last 7 days
-0.2%
Last 30 days
-2.6%
Last 90 days
20.5%
Trailing 12 Months
42.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 9.2B | 9.5B | 9.7B | 9.9B |
2022 | 7.9B | 8.4B | 8.7B | 8.9B |
2021 | 6.4B | 6.7B | 7.1B | 7.6B |
2020 | 4.8B | 5.4B | 6.0B | 6.2B |
2019 | 3.3B | 3.5B | 3.6B | 4.2B |
2018 | 2.4B | 2.6B | 2.8B | 3.0B |
2017 | 2.0B | 2.1B | 2.3B | 2.5B |
2016 | 1.3B | 1.6B | 1.7B | 1.7B |
2015 | 600.5M | 628.1M | 759.0M | 1.0B |
2014 | 1.0B | 829.7M | 787.0M | 580.4M |
2013 | 1.4B | 1.3B | 1.2B | 1.2B |
2012 | 1.8B | 2.1B | 1.8B | 1.5B |
2011 | 194.6M | 277.4M | 912.8M | 1.4B |
2010 | 100.3M | 112.9M | 111.7M | 143.4M |
2009 | 157.1M | 138.7M | 120.3M | 101.9M |
2008 | 0 | 0 | 0 | 175.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 26, 2024 | ambrose kristen | sold | -375,893 | 425 | -883 | svp & chief accounting officer |
Feb 26, 2024 | tatsis ourania | sold | -150,698 | 425 | -354 | evp, chief reg. & quality off. |
Feb 26, 2024 | sachdev amit | sold | -1,278,800 | 425 | -3,004 | evp chief patient & ext af off |
Feb 26, 2024 | arbuckle stuart a | sold | -2,142,970 | 425 | -5,034 | evp, coo |
Feb 26, 2024 | atkinson edward morrow iii | sold | -375,893 | 425 | -883 | evp, chief technical ops. off. |
Feb 26, 2024 | altshuler david | sold | -1,804,540 | 425 | -4,239 | evp, global research and cso |
Feb 23, 2024 | atkinson edward morrow iii | sold (taxes) | -714,181 | 431 | -1,654 | evp, chief technical ops. off. |
Feb 23, 2024 | sachdev amit | sold (taxes) | -1,066,090 | 431 | -2,469 | evp chief patient & ext af off |
Feb 23, 2024 | kewalramani reshma | sold (taxes) | -4,052,780 | 431 | -9,386 | ceo & president |
Feb 23, 2024 | tatsis ourania | sold (taxes) | -1,428,790 | 431 | -3,309 | evp, chief reg. & quality off. |
Which funds bought or sold VRTX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 14, 2024 | ABLES, IANNONE, MOORE & ASSOCIATES, INC. | new | - | 1,628 | 1,628 | -% |
Mar 13, 2024 | Sivia Capital Partners, LLC | new | - | 295,402 | 295,402 | 0.22% |
Mar 12, 2024 | Spartan Planning & Wealth Management | reduced | -75.44 | -112,013 | 45,165 | 0.05% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.36 | 1,421,900,000 | 9,066,400,000 | 0.20% |
Mar 08, 2024 | TRUST CO OF VERMONT | reduced | -3.34 | 16,352 | 141,191 | 0.01% |
Mar 08, 2024 | ICA Group Wealth Management, LLC | new | - | 28,481 | 28,481 | 0.01% |
Mar 06, 2024 | SageView Advisory Group, LLC | added | 176 | 2,037,460 | 2,837,960 | 0.12% |
Mar 06, 2024 | WILLNER & HELLER, LLC | new | - | 406,483 | 406,483 | 0.45% |
Mar 05, 2024 | GREENWOOD CAPITAL ASSOCIATES LLC | added | 122 | 12,707,600 | 20,625,300 | 1.34% |
Mar 05, 2024 | True Vision MN LLC | new | - | 379,221 | 379,221 | 0.30% |
Unveiling Vertex Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Vertex Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 39.7B | 6.8B | -8.42 | 5.79 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.8B | 1.8B | -42.7 | 10.28 | ||||
BMRN | 15.8B | 2.4B | 94.39 | 6.54 | ||||
INCY | 13.1B | 3.7B | 21.93 | 3.55 | ||||
MID-CAP | ||||||||
APLS | 6.8B | 396.6M | -12.94 | 17.25 | ||||
BBIO | 4.8B | - | -7.42 | 60.35 | ||||
AXSM | 3.6B | 270.6M | -14.96 | 13.22 | ||||
ARWR | 3.5B | 240.7M | -11.8 | 14.55 | ||||
ACAD | 3.0B | 726.4M | -49.68 | 4.19 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.52 | 4.76 | ||||
NVAX | 740.4M | 983.7M | -1.36 | 0.75 | ||||
CRBP | 458.3M | 881.7K | -10.28 | 530.54 | ||||
INO | 250.8M | 4.9M | -1.86 | 51.53 | ||||
IBIO | 3.7M | 2.1M | -0.13 | 2.14 |
Vertex Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 1.4% | 2,518 | 2,484 | 2,493 | 2,375 | 2,303 | 2,334 | 2,196 | 2,098 | 2,073 | 1,984 | 1,793 | 1,724 | 1,628 | 1,538 | 1,524 | 1,515 | 1,413 | 950 | 941 | 858 | 870 |
Costs and Expenses | 5.8% | 1,529 | 1,445 | 1,467 | 1,596 | 1,269 | 1,208 | 1,090 | 1,057 | 1,195 | 930 | 1,831 | 837 | 882 | 866 | 806 | 795 | 862 | 850 | 671 | 582 | 742 |
S&GA Expenses | 39.9% | 369 | 264 | 263 | 241 | 267 | 247 | 215 | 215 | 255 | 198 | 195 | 192 | 212 | 185 | 192 | 182 | 195 | 160 | 157 | 147 | 153 |
R&D Expenses | - | - | - | - | - | - | - | - | 603 | 694 | 494 | 1,407 | 456 | 467 | 493 | 421 | 449 | 480 | 556 | 379 | 339 | 438 |
EBITDA Margin | -0.2% | 0.46* | 0.46* | 0.46* | 0.46* | 0.48* | 0.47* | 0.48* | 0.37* | 0.37* | 0.40* | 0.37* | 0.52* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 2.8% | -10.60 | -10.90 | -11.20 | -11.40 | -11.60 | -13.70 | -14.60 | -14.90 | -15.10 | -15.20 | -15.50 | -15.70 | 16.00 | -13.86 | -13.87 | -14.14 | 14.00 | 15.00 | 15.00 | 15.00 | 19.00 |
Income Taxes | 24.3% | 179 | 144 | 246 | 192 | 258 | 246 | 214 | 193 | 101 | 231 | -111 | 168 | 284 | 78.00 | -12.50 | 55.00 | 94.00 | 13.00 | 60.00 | 52.00 | -1,492 |
Earnings Before Taxes | -2.7% | 1,148 | 1,179 | 1,162 | 892 | 1,077 | 1,176 | 1,024 | 955 | 871 | 1,083 | -44.20 | 821 | 889 | 746 | 825 | 658 | 677 | 71.00 | 327 | 320 | 32.00 |
EBT Margin | -0.6% | 0.44* | 0.45* | 0.45* | 0.45* | 0.47* | 0.46* | 0.47* | 0.36* | 0.36* | 0.39* | 0.36* | 0.51* | - | - | - | - | - | - | - | - | - |
Net Income | -6.4% | 969 | 1,035 | 916 | 700 | 819 | 931 | 811 | 762 | 770 | 852 | 67.00 | 653 | 604 | 667 | 837 | 603 | 583 | 58.00 | 267 | 269 | 1,551 |
Net Income Margin | 2.0% | 0.37* | 0.36* | 0.35* | 0.35* | 0.37* | 0.38* | 0.38* | 0.31* | 0.31* | 0.31* | 0.30* | 0.43* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -85.6% | 177 | 1,228 | 1,075 | 858 | 1,045 | 901 | 1,087 | 893 | 933 | 875 | -249 | 850 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 4.6% | 22,730 | 21,726 | 20,349 | 18,974 | 18,151 | 16,706 | 15,582 | 14,256 | 13,433 | 12,619 | 12,222 | 12,115 | 11,752 | 11,302 | 10,216 | 8,893 | 8,318 | 7,515 | 7,033 | 6,543 | 6,246 |
Current Assets | -3.8% | 14,144 | 14,696 | 13,873 | 12,966 | 13,235 | 12,271 | 11,504 | 10,361 | 9,561 | 8,853 | 8,458 | 8,539 | 8,133 | 7,458 | 6,694 | 5,446 | 4,823 | 4,777 | 4,711 | 4,183 | 3,843 |
Cash Equivalents | -6.7% | 10,369 | 11,110 | 10,151 | 9,290 | 10,504 | 9,172 | 8,702 | 7,600 | 6,795 | 6,276 | 6,064 | 6,304 | 5,988 | 5,358 | 4,831 | 3,593 | 3,109 | 3,398 | 3,295 | 2,894 | 2,650 |
Inventory | 7.3% | 739 | 689 | 604 | 535 | 461 | 388 | 368 | 339 | 353 | 333 | 322 | 299 | 281 | 245 | 219 | 187 | 168 | 162 | 143 | 137 | 124 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 921 | 728 | 736 | 745 | 17.00 | 731 | 743 | 812 |
Goodwill | 0% | 1,088 | 1,088 | 1,088 | 1,088 | 1,100 | 86.00 | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 | 1,000 | 1,002 | 1,002 | 1,002 | 1,002 | 448 | 50.00 | 50.00 | 50.00 |
Liabilities | -1.2% | 5,150 | 5,213 | 4,879 | 4,542 | 4,238 | 3,677 | 3,649 | 3,349 | 3,333 | 3,088 | 3,025 | 3,135 | 3,065 | 3,168 | 2,697 | 2,432 | 2,233 | 2,261 | 1,964 | 1,820 | 1,811 |
Current Liabilities | -1.4% | 3,547 | 3,599 | 3,352 | 3,026 | 2,742 | 2,609 | 2,556 | 2,180 | 2,142 | 1,914 | 1,836 | 1,944 | 1,878 | 2,004 | 1,799 | 1,539 | 1,335 | 1,389 | 1,259 | 1,106 | 1,120 |
Shareholder's Equity | 6.5% | 17,580 | 16,513 | 15,470 | 14,432 | 13,913 | 13,030 | 11,934 | 10,907 | 10,100 | 9,531 | 9,196 | 8,980 | 8,687 | 8,133 | 7,519 | 6,462 | 6,085 | 5,253 | 5,070 | 4,723 | 4,435 |
Retained Earnings | 10.6% | 10,142 | 9,174 | 8,138 | 7,223 | 6,523 | 5,704 | 4,773 | 3,963 | 3,201 | 2,431 | 1,579 | 1,512 | 859 | 254 | -412 | -1,250 | -1,852 | -2,436 | -2,493 | -2,761 | -2,989 |
Additional Paid-In Capital | 1.5% | 7,450 | 7,340 | 7,369 | 7,220 | 7,387 | 7,226 | 7,100 | 6,930 | 6,881 | 7,086 | 7,640 | 7,499 | 7,894 | 7,917 | 7,944 | 7,696 | 7,938 | 7,668 | 7,564 | 7,476 | 7,421 |
Shares Outstanding | -0.1% | 258 | 258 | 258 | 258 | 257 | 256 | 256 | 255 | 258 | 258 | 259 | 259 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 90,700 | - | - | - | 71,800 | - | - | - | 51,600 | - | - | - | 74,800 | - | - | - | 46,700 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -81.5% | 235 | 1,268 | 1,134 | 900 | 1,078 | 956 | 1,140 | 956 | 995 | 927 | -199 | 921 | 492 | 908 | 1,039 | 816 | 446 | 335 | 464 | 325 | 315 |
Share Based Compensation | 59.4% | 209 | 131 | 119 | 122 | 112 | 136 | 114 | 130 | 119 | 103 | 105 | 115 | 97.00 | 100 | 117 | 116 | 92.00 | 85.00 | 90.00 | 94.00 | 79.00 |
Cashflow From Investing | -653.2% | -886 | -117 | -303 | -1,833 | 176 | -384 | -61.50 | -51.00 | -134 | -52.90 | -79.70 | -74.30 | 244 | -247 | 72.00 | 32.00 | -896 | -249 | -50.19 | -39.14 | -40.90 |
Cashflow From Financing | 27.4% | -119 | -165 | 17.00 | -294 | 40.00 | -60.20 | 48.00 | -95.40 | -336 | -656 | 34.00 | -518 | -125 | -140 | 120 | -359 | 161 | 20.00 | -13.01 | -41.99 | -101 |
Buy Backs | 20.2% | 148 | 123 | 26.00 | 133 | - | - | - | - | 363 | 642 | - | 425 | 131 | 108 | - | 300 | 32.00 | 12.00 | 52.00 | 94.00 | 142 |
Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Revenue | $ 9,869.2 | $ 8,930.7 | $ 7,574.4 |
Costs and expenses: | |||
Cost of sales | 1,262.2 | 1,080.3 | 904.2 |
Research and development expenses | 3,162.9 | 2,540.3 | 1,937.8 |
Acquired in-process research and development expenses | 527.1 | 115.5 | 1,113.3 |
Selling, general and administrative expenses | 1,136.6 | 944.7 | 840.1 |
Change in fair value of contingent consideration | (51.6) | (57.5) | (3.1) |
Total costs and expenses | 6,037.2 | 4,623.3 | 4,792.3 |
Income from operations | 3,832.0 | 4,307.4 | 2,782.1 |
Interest income | 614.7 | 144.6 | 4.9 |
Interest expense | (44.1) | (54.8) | (61.5) |
Other (expense) income, net | (22.8) | (164.8) | 4.9 |
Income before provision for income taxes | 4,379.8 | 4,232.4 | 2,730.4 |
Provision for income taxes | 760.2 | 910.4 | 388.3 |
Net income | $ 3,619.6 | $ 3,322.0 | $ 2,342.1 |
Net income per common share: | |||
Basic (in dollars per share) | $ 14.05 | $ 12.97 | $ 9.09 |
Diluted (in dollars per share) | $ 13.89 | $ 12.82 | $ 9.01 |
Shares used in per share calculations: | |||
Basic (in shares) | 257.7 | 256.1 | 257.7 |
Diluted (in shares) | 260.5 | 259.1 | 259.9 |
Product revenues, net | |||
Revenues: | |||
Revenue | $ 9,869.2 | $ 8,930.7 | $ 7,573.4 |
Other revenues | |||
Revenues: | |||
Revenue | $ 0.0 | $ 0.0 | $ 1.0 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 10,369.1 | $ 10,504.0 |
Marketable securities | 849.2 | 274.5 |
Accounts receivable, net | 1,563.4 | 1,442.2 |
Inventories | 738.8 | 460.6 |
Prepaid expenses and other current assets | 623.7 | 553.5 |
Total current assets | 14,144.2 | 13,234.8 |
Property and equipment, net | 1,159.3 | 1,108.4 |
Goodwill | 1,088.0 | 1,088.0 |
Other intangible assets, net | 839.9 | 603.6 |
Deferred tax assets | 1,812.1 | 1,246.9 |
Operating lease assets | 293.6 | 347.4 |
Long-term marketable securities | 2,497.8 | 112.2 |
Other assets | 895.3 | 409.6 |
Total assets | 22,730.2 | 18,150.9 |
Current liabilities: | ||
Accounts payable | 364.9 | 303.9 |
Accrued expenses | 2,655.3 | 2,126.7 |
Other current liabilities | 527.2 | 311.5 |
Total current liabilities | 3,547.4 | 2,742.1 |
Long-term finance lease liabilities | 376.1 | 430.8 |
Long-term operating lease liabilities | 348.6 | 379.5 |
Other long-term liabilities | 877.7 | 685.8 |
Total liabilities | 5,149.8 | 4,238.2 |
Commitments and contingencies | 0.0 | 0.0 |
Shareholders’ equity: | ||
Preferred stock, $0.01 par value; 1,000,000 shares authorized; none issued and outstanding | 0.0 | 0.0 |
Common stock, $0.01 par value; 500,000,000 shares authorized, 257,695,221 and 257,011,628 shares issued and outstanding, respectively | 2.6 | 2.6 |
Additional paid-in capital | 7,449.7 | 7,386.5 |
Accumulated other comprehensive (loss) income | (14.3) | 0.8 |
Retained earnings | 10,142.4 | 6,522.8 |
Total shareholders’ equity | 17,580.4 | 13,912.7 |
Total liabilities and shareholders’ equity | $ 22,730.2 | $ 18,150.9 |